German firm to invest in Russian syringe plant

According to company CEO Jan Kostshevsky, the new plant will have capacity to produce up to 150 million disposable syringes each year and will compete with Chinese producers. Financial details were not disclosed.

Most of the syringes produced at the site will be sold within Omsk (where demand for syringes is estimated at between 33-35 million a year) and neighbouring regions.

The construction of the new plant is part of a major project being planned for Siberia, which aims to establish of an industrial cluster for production of medical equipment.

A PP resins plant at Omsk, which is scheduled to be launched later this year, is expected to provide raw materials for the Farmar facility.

Based in Munich, Farmar is a holding company that specialises in provision of medical services to overseas markets. In Russia, the company has offices in the Moscow and Perm regions.

[ Back ]